BA
ABMD

Bridgewater Associates’s Abiomed Inc ABMD Stock Holding History

Bridgewater Associates’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-92,377
Closed -$22.7M – 951
2022
Q3 		$22.7M Buy
92,377
+2,152
+2% +$581K 0.11% 144
2022
Q2 		$22.3M Buy
90,225
+23,353
+35% +$6.3M 0.09% 186
2022
Q1 		$22.2M Buy
66,872
+17,874
+36% +$5.5M 0.09% 163
2021
Q4 		$17.6M Buy
48,998
+2,451
+5% +$828K 0.1% 135
2021
Q3 		$15.2M Sell
46,547
-2,374
-5% -$804K 0.08% 152
2021
Q2 		$15.3M Buy
48,921
+17,920
+58% +$5.5M 0.1% 162
2021
Q1 		$9.88M Buy
31,001
+5,084
+20% +$1.63M 0.09% 163
2020
Q4 		$8.4M Buy
25,917
+15,226
+142% +$4.21M 0.07% 145
2020
Q3 		$2.96M Buy
+10,691
New +$3.08M 0.04% 206

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bridgewater Associates's ABMD Position: Q4 2022 in Review

Bridgewater Associates sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 92,377 shares — an estimated $22.7M sold.

Bridgewater Associates first reported a position in ABMD in Q3 2020 and held it in 9 quarters. The position peaked at $22.7M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Bridgewater Associates reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Bridgewater Associates sold 92,377 Abiomed Inc shares in Q4 2022, an estimated $22.7M.
  • Bridgewater Associates first reported a position in Abiomed Inc in Q3 2020 and held it in 9 quarters.
  • Bridgewater Associates's Abiomed Inc position peaked at $22.7M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bridgewater Associates's 13F filing for Q4 2022, filed 13 Feb 2023.